HGH Fragment 176-191 CJC-1295 DAC Blend Vial New Zealand

Description

HGH Fragment 176-191 CJC-1295 DAC Blend Peptide Vial 2.5mg New Zealand

This product is intended for research purposes only. To be used by trained professionals only.

The HGH Fragment 176-191 CJC-1295 DAC Blend 2.5mg peptide vial represents an innovative combination specifically formulated to enhance growth hormone dynamics and support anabolic processes.

HGH Fragment, a modified version of human growth hormone, is tailored to emphasise lipolytic (fat-burning) effects while minimising other undesirable growth-related effects. This targeted action is particularly beneficial for body composition improvements, as it aids in fat loss while preserving lean muscle mass.

When combined with CJC-1295 DAC, which is known for its ability to extend the half-life of growth hormone release, this blend achieves a sustained anabolic environment conducive to muscle development and recovery. The 2.5mg dosage is ideal for research applications, facilitating consistent intake and promoting the desired physiological adaptations.

This blend offers a compelling avenue for studies related to body composition, performance enhancement, and overall metabolic health, making it a valuable tool in the fields of sports science and endocrinology.

For details on these individual peptides, including their mechanisms, benefits, side effects, and available products offered by Direct Peptides New Zealand, visit their respective category pages:

Key Features of HGH Fragment 176-191 CJC-1295 DAC Blend (2.5mg)

Targeted Anabolic Action: Specifically designed to enhance growth hormone dynamics while promoting fat loss and preserving lean muscle mass.
Enhanced Fat Metabolism: The inclusion of HGH Fragment focuses on lipolytic effects, facilitating effective fat reduction.
Sustained Growth Hormone Release: CJC-1295 DAC extends the half-life of growth hormone, allowing for prolonged anabolic efficacy.
Optimal Dosage for Research: The 2.5mg formulation is ideal for consistent dosing, ensuring reliable results in research applications.
Supports Muscle Development: Promotes muscle growth and recovery, making it beneficial for athletes and fitness enthusiasts.
Versatile Research Applications: Useful in studies exploring growth hormone deficiencies, body composition, performance enhancement, and metabolic health.
Non-invasive Administration: Designed for easy use, ensuring better compliance in research environments.
Innovative Combination: Leverages the synergistic effects of HGH Fragment and CJC-1295 DAC to maximize anabolic outcomes.

Shop ALL Peptide Blends from Direct Peptides New Zealand

Shipping and Handling

Shipping and handling of HGH Fragment 176-191 CJC-1295 DAC Blend (2.5mg) is conducted with utmost care to ensure product integrity, employing temperature-controlled packaging and expedited delivery options to meet research requirements efficiently.

Storage

The HGH Fragment and CJC-1295 DAC Blend (2.5mg) should be stored in a cool, dry place, ideally between 2°C to 8°C (36°F to 46°F), and protected from light to maintain its stability and efficacy until use.

Reconstitution of HGH Fragment 176-191 CJC-1295 DAC Blend 2.5mg Peptide Vial

The reconstitution of the HGH Fragment 176-191 CJC-1295 DAC Blend 2.5mg vial is vital for ensuring the formulation’s stability and effectiveness. It should be done in a sterile environment to prevent contamination. Begin by handling the lyophilised powder with clean hands and using a suitable syringe to add sterile diluent, like bacteriostatic water or saline.

Gently swirl the vial to mix, avoiding vigorous shaking. After full dissolution, inspect the solution for clarity and ensure immediate administration or proper storage. Documenting the reconstitution date and procedure is essential for maintaining accurate research and clinical records.

Buy high quality research grade peptide supplies here for your scientific study requirements from Direct Peptides New Zealand. Our selection encompasses syringes, empty cartridges, and a pen needle pack, meticulously designed to aid researchers in the efficient reconstitution of peptides.

References:

[1] M Heffernan, R J Summers, A Thorburn, E Ogru, R Gianello, W J Jiang, F M Ng (2001) The effects of human GH and its lipolytic fragment (AOD9604) on lipid metabolism following chronic treatment in obese mice and beta(3)-AR knock-out mice – Endocrinology, 2001 Dec, Volume 142 (Issue 12), Pages 5182-9.

[2] S L Teichman, A Neale, B Lawrence, C Gagnon, JP Castaigne, L A Frohman (2006) Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults – Journal of Clinical Endocrinology and Metabolism, 2006 Mar, Volume 91 (Issue 3), Pages 799-805.

ALL CONTENT AND PRODUCT INFORMATION AVAILABLE ON THIS WEBSITE IS FOR EDUCATIONAL PURPOSES ONLY.

DISCLAIMER: These products are intended solely as a research chemical only. This classification allows for their use only for research development and laboratory studies. The information available on our New Zealand Direct Peptides website: https://new-zealand.direct-peptides.com is provided for educational purposes only. These products are not for human or animal use or consumption in any manner. Handling of these products should be limited to suitably qualified professionals. They are not to be classified as a drug, food, cosmetic, or medicinal product and must not be mislabelled or used as such.

BUY HGH Fragment 176-191 CJC-1295 DAC Blend Peptide Vial ONLINE today From Direct Peptides